A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events

By Addison Christina   Bouganim Nathaniel   Hilton John   Vandermeer Lisa   Dent Susan   Amir Eitan   Hopkins Sean   Kuchuk Iryna   Segal Roanne   Song Xinni   Gertler Stan   Mazzarello Sasha   Dranitsaris George   Ooi Daylily   Pond Gregory   Clemons Mark  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 615-624

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

By Guarneri Valentina  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

By Kristensen Bent   Ejlertsen Bent   Mouridsen Henning   Jensen Maj-Britt   Andersen Jørn   Bjerregaard Brita   Cold Søren   Edlund Per   Ewertz Marianne   Kamby Claus   Lindman Henrik   Nordenskjold Bo   Bergh Jonas  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 740-746

Informa Healthcare

Access to resources Recommend Favorite

Local Therapy in Stage IV Breast Cancer Patients

By Fitzal F.  

Annals of Surgical Oncology, Vol. 15, Iss. 9, 2008-09 ,pp. : 2618-2618

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Therapy in Elderly Patients with Early Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 315-325

Bentham Science Publishers

Access to resources Recommend Favorite